Effects of oral contraceptives on metabolic profile in women with polycystic ovary syndrome: A meta-analysis comparing products containing cyproterone acetate with third generation progestins

Mina Amiri(Research Institute for Endocrine Sciences), Enrico Carmina(OHB (Italy)), Ali Kabir(University of Washington), Fahimeh Ramezani Tehrani(Research Institute for Endocrine Sciences), Fatemeh Nahidi(Shahid Beheshti University of Medical Sciences), Fereidoun Azizi(Research Institute for Endocrine Sciences)
Metabolism
May 10, 2017
10.1016/j.metabol.2017.05.001
Cited by 69

Related Papers

Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults
|The Lancet|2017|7.7k
Consensus on women’s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group
|Fertility and Sterility|2011|2k
Polycystic ovary syndrome
|Nature Reviews Disease Primers|2016|1.9k
American Association of Clinical Endocrinologists, American College of Endocrinology, and Androgen Excess and PCOS Society Disease State Clinical Review: Guide to the Best Practices in the Evaluation and Treatment of Polycystic Ovary Syndrome - Part 1
|Endocrine Practice|2015|628
Polycystic Ovary Syndrome (PCOS): Arguably the Most Common Endocrinopathy Is Associated with Significant Morbidity in Women
|The Journal of Clinical Endocrinology & Metabolism|1999|508